Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3DZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,367
Award facts
- Contract value 100% obligated
- $37,367.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $37,367.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen auto-injectors on January 9, 2026, with an ultimate completion date of January 12, 2026. This contract was not set-aside and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Zepbound, a GLP-1 receptor agonist used for weight management, represents part of the broader pharmaceutical supply needs of the Department of Defense's medical programs.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s existing Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999.9 million through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, covering specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. AmerisourceBergen Drug Corp's demonstrated capability to efficiently fulfill government contracts for essential pharmaceutical products through this competitive vehicle underscores its critical role in supporting the Defense Health Agency and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FG3DZ?
SPE2DR26FG3DZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FG3DZ worth?
The government has obligated $37,367 on SPE2DR26FG3DZ.
Is contract SPE2DR26FG3DZ an order under another contract?
Yes. SPE2DR26FG3DZ is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3DZ competed?
The extent of competition for SPE2DR26FG3DZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award